Why Expedia Group (EXPE) Stock Is Up Today

Expedia Group (EXPE) is up 7.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a mix of fresh analyst optimism and continued confidence in Expedia’s growth story ahead of its next earnings report. Investors also seem to be responding to the company’s strong first-quarter execution, ongoing buybacks, and expansion of its B2B travel platform.

Details:

A recent analyst update assigned an Outperform rating and a $334 price target, signaling notable upside from recent trading levels.

In first-quarter 2026 results, Expedia said gross bookings rose 13%, revenue increased 15%, and adjusted EBITDA jumped 83% year over year.

Management kept its full-year 2026 outlook in place, including revenue guidance of $15.6 billion to $16.0 billion, which may be reinforcing confidence ahead of the August 5, 2026 earnings release.

Expedia also repurchased $700 million of stock in the first quarter, authorized a new $5 billion buyback, and announced a deal to acquire CarTrawler to deepen its B2B mobility and travel-services offering.

Sources:

Expedia Group Investor Relations, SEC, Benzinga

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$EXPE Insider Trading Activity

$EXPE insiders have traded $EXPE stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $EXPE stock by insiders over the last 6 months:

ROBERT J DZIELAK (Chief Legal Officer & Sec'y) sold 4,702 shares for an estimated $1,095,566
LANCE A SOLIDAY (SVP & Chief Accounting Officer) sold 940 shares for an estimated $208,547

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$EXPE Hedge Fund Activity

We have seen 491 institutional investors add shares of $EXPE stock to their portfolio, and 537 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WINDACRE PARTNERSHIP LLC added 1,081,300 shares (+46.0%) to their portfolio in Q1 2026, for an estimated $244,454,897
NUVEEN, LLC removed 829,329 shares (-65.3%) from their portfolio in Q1 2026, for an estimated $187,490,553
AQR CAPITAL MANAGEMENT LLC removed 819,642 shares (-24.3%) from their portfolio in Q1 2026, for an estimated $185,300,565
DEUTSCHE BANK AG\ removed 804,004 shares (-62.5%) from their portfolio in Q1 2026, for an estimated $181,765,204
GEODE CAPITAL MANAGEMENT, LLC added 702,933 shares (+21.2%) to their portfolio in Q1 2026, for an estimated $158,915,577
ACADIAN ASSET MANAGEMENT LLC added 684,635 shares (+106.3%) to their portfolio in Q1 2026, for an estimated $154,778,857
BOSTON PARTNERS added 676,698 shares (+inf%) to their portfolio in Q1 2026, for an estimated $152,984,500

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$EXPE Congressional Stock Trading

Members of Congress have traded $EXPE stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $EXPE stock by members of Congress over the last 6 months:

SENATOR ALAN ARMSTRONG sold up to $50,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$EXPE Analyst Ratings

Wall Street analysts have issued reports on $EXPE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 05/08/2026

To track analyst ratings and price targets for $EXPE, check out Quiver Quantitative's $EXPE forecast page.

$EXPE Price Targets

Multiple analysts have issued price targets for $EXPE recently. We have seen 17 analysts offer price targets for $EXPE in the last 6 months, with a median target of $262.0.

Here are some recent targets:

John Staszak from Argus Research set a target price of $315.0 on 07/07/2026
Ken Gawrelski from Wells Fargo set a target price of $303.0 on 06/30/2026
Jake Fuller from BTIG set a target price of $330.0 on 06/09/2026
Tom White from DA Davidson set a target price of $250.0 on 05/18/2026
Shyam Patil from Susquehanna set a target price of $250.0 on 05/11/2026
Trevor Young from Barclays set a target price of $264.0 on 05/11/2026
Thomas Champion from Piper Sandler set a target price of $245.0 on 05/08/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.